Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1281895 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $3.14Day −3.38%Mkt cap $343M1Y +1.0%Off 52W high −42.4%Vol (1Y) 76.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,872 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest15.2% of sh out |
| Days to cover6.8d |
| 13F net flow (QoQ)+11.60% |
| Top-10 13F concentration58.2% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$209.4M |
| ROE−60.3% |
| ROIC−204.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−10.5% |
| 1Y+1.0% |
| 3Y−82.6% |
| 5Y−91.9% |
| 10Y−91.7% |
| Since incept. (ann.)−16.3% |
Total return through 2026-07-28 · series begins 2015-02-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)76.5% |
| Ann. volatility (3Y)81.0% |
| Sharpe (1Y)0.38 |
| Sharpe (3Y)−0.24 |
| Max drawdown (1Y)−49.8% |
| Max drawdown (3Y)−92.7% |
| Beta (3Y vs SPY)0.40 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | 17.7M | $63M | 16.20% | +0.0% |
| BlackRock, Inc. | 7.8M | $28M | 7.18% | −0.9% |
| CITIGROUP INC | 5.1M | $18M | 4.68% | −2.6% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7M | $17M | 4.30% | new |
| STATE STREET CORP | 4.5M | $16M | 4.11% | +163.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.8M | $14M | 3.46% | new |
| MAVERICK CAPITAL LTD | 3.6M | $13M | 3.27% | +42.0% |
| Newtyn Management, LLC | 3.2M | $11M | 2.90% | +19.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.42 | — | $0 | — |
| 2025-12-31 | 2026-02-26 | — | — | $0 | — |
| 2025-09-30 | 2025-11-06 | −$0.45 | — | $0 | — |
| 2025-06-30 | 2025-08-07 | −$0.62 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
